Urinary Incontinence - Market Insights, Epidemiology and Market Forecast -2023-7MM

Publisher Name :
Date: 31-Mar-2017
No. of pages: 77
Delivery of the Report will take 2-3 working days once order is placed.

DelveInsight's "Urinary Incontinence - Market Insights, Epidemiology and Market Forecast-2023-7MM" Reports provides an overview of the disease and global market size of the Urinary Incontinence for the United States, EU5 (France, Germany, Italy, Spain, UK) and Japan. It also includes historical and forecasted epidemiological data for the prevalent cases of Urinary Incontinence from 2013-2023.

Urinary Incontinence is a multifactorial syndrome which occurs due to the failure of the storage function of the lower urinary tract and loss of bladder control resulting in leakage of urine. Embarrassment, isolation, and depression are observed among patients with Urinary Incontinence. Millions of individuals worldwide are suffering from Urinary Incontinence. It is most common among the old people. It increases the chances of developing several medical conditions such as local skin irritation, rashes, and urinary infections.

According to DelveInsight, the market size for Urinary Incontinence of 7 MM is estimated to be USD XX Million by 2023 at a CAGR of 9.5% for the forecast period i.e., 2013-2023.

The report is built using data and information sourced from proprietary databases, primary and secondary research and in-house Forecast model analysis by Publisher team of industry experts.

Scope

The report will help in developing business strategies by understanding the trends shaping and driving the Urinary Incontinence market.

Organize sales and marketing efforts by identifying the best opportunities for Urinary Incontinence in US, Europe (Germany, Spain, Italy, France and United Kingdom) and Japan.

To understand the future market competition in the 7MM market of Urinary Incontinence and Insightful review of the key market drivers and barriers.

To understand the regulatory scenario in major markets.

The Report also covers the detailed historical and forecasted Urinary Incontinence market covering United States, Europe (Germany, Spain, Italy, France and United Kingdom) and Japan from 2013-2023.

Urinary Incontinence - Market Insights, Epidemiology and Market Forecast -2023-7MM

Table of Contents

Report Introduction
Urinary Incontinence Market Overview at a Glance
7 MM Market Size of Urinary Incontinence (2013-2023)
Total Market Share Distribution of Urinary Incontinence for 7 MM in 2016
Total Market Share Distribution of Urinary Incontinence for 7 MM in 2023
Urinary Incontinence
Overview
Pathophysiology
Etiology
Risk factors
Diagnosis
Treatment
Epidemiology and Patient Population
Total number of Prevalent cases - 7MM Countries - (2016 & 2023)
Secondary Studies referred
United States
Prevalent Cases of Urinary Incontinence in United States
Percentage Distribution ofUrinary Incontinence by Sub Types
Germany
Prevalent Cases of Urinary Incontinence in Germany
Percentage Distribution ofUrinary Incontinence by Sub Types
France
Prevalent Cases of Urinary Incontinence in France
Percentage Distribution ofUrinary Incontinence by Sub Types
United Kingdom
Prevalent Cases of Urinary Incontinence in United Kingdom
Percentage Distribution ofUrinary Incontinence by Sub Types
Spain
Prevalent Cases of Urinary Incontinence in Spain
Percentage Distribution ofUrinary Incontinence by Sub Types
Italy
Prevalent Cases of Urinary Incontinence in Italy
Percentage Distribution ofUrinary Incontinence by Sub Types
Japan
Prevalent Cases of Urinary Incontinence in Japan
Percentage Distribution ofUrinary Incontinence by Sub Types
Treatment Algorithm
Current Unmet Needs
Marketed Drugs
Major Marketed Drugs
Myrbetriq\ Betmiga\Betani
Description
Regulatory Milestones
Advantages and Disadvantages
Product Profile
Efficacy
Safety
Side effects
Botox
Description
Regulatory Milestones
Advantages and Disadvantages
Product Profile
Efficacy
Safety
Side effects
Toviaz
Description
Regulatory Milestones
Advantages and Disadvantages
Product Profile
Efficacy
Safety
Side effects
VESIcare
Description
Regulatory Milestones
Advantages and Disadvantages
Product Profile
Efficacy
Safety
Side effects
Emerging Therapies
Key Emerging Therapies
Vibegron: Kissei Pharmaceutical Co., Ltd.
Product Development Activities
Clinical Development
Product Profile
Clinical Trial by Phase
AbobotulinumtoxinA: Ipsen Group
Clinical Development
Product Profile
Clinical Trial by Phase
Mirabegron+Solifenacin: Astellas Pharma Inc.
Product Development Activities
Clinical Development
Product Profile
Clinical Trial by Phase
Global Urinary Incontinence: Country-Wise Market Analysis
Overview on Total Urinary Incontinence Market (2016)
Overview on Total Urinary Incontinence Market (2023)
Global Urinary incontinence: Market Analysis
United States Market Size
Europe Market Size
Germany Market Size
France Market Size
United Kingdom Market Size
Spain Market Size
Italy Market Size
Japan Market Size
Market Drivers
Market Barriers
Report Methodology
Consulting Services
Disclaimer
About DelveInsight

List of Tables

Table 1: 7 MM Market Size of Urinary Incontinence in USD Million (2013-2023)
Table 2: Prevalent Cases Urinary Incontinence in United States (2013-2023)
Table 3: Percentage Distribution of Urinary Incontinence by Sub Types in United States (2016)
Table 4: Prevalent Cases Urinary Incontinence in Germany (2013-2023)
Table 5: Percentage Distribution of Urinary Incontinence by Sub Types in Germany (2016)
Table 6: Prevalent Cases Urinary Incontinence in France (2013-2023)
Table 7: Percentage Distribution of Urinary Incontinence by Sub Types in France (2016)
Table 8: Prevalent Cases Urinary Incontinence in United Kingdom (2013-2023)
Table 9: Percentage Distribution of Urinary Incontinence by Sub Types in United Kingdom (2016)
Table 10: Prevalent Cases Urinary Incontinence in Spain (2013-2023)
Table 11: Percentage Distribution of Urinary Incontinence by Sub Types in Spain (2016)
Table 12: Prevalent Cases Urinary Incontinence in Italy (2013-2023)
Table 13: Percentage Distribution of Urinary Incontinence by Sub Types in Italy (2016)
Table 14: Prevalent Cases Urinary Incontinence in Japan (2013-2023)
Table 15: Percentage Distribution of Urinary Incontinence by Sub Types in Japan (2016)
Table 16: Marketed Drugs for Urinary Incontinence
Table 17: Emerging Therapies for Urinary Incontinence
Table 18: Total Urinary Incontinence , Distribution share (2016) as per the 7MM
Table 19: Total Urinary Incontinence , Distribution share (2023) as per the 7MM
Table 20: United States Market Size of Urinary Incontinence in USD, Million (2013-2023)
Table 21: Germany Market Size of Urinary Incontinence in USD, Million (2013-2023)
Table 22: France Market Size of Urinary Incontinence in USD, Million (2013-2023)
Table 23: United Kingdom Market Size of Urinary Incontinence in USD, Million (2013-2023)
Table 24: Spain Market Size of Urinary Incontinence in USD, Million (2013-2023)
Table 25: Italy Market Size of Urinary Incontinence in USD, Million (2013-2023)
Table 26: Japan Market Size of Urinary Incontinence in USD, Million (2013-2023)

List of Figures

Figure 1:Types of Urinary Incontinence
Figure 2:Risk Factors of Urinary Incontinence
Figure 3:Treatment of Urinary Incontinence
Figure 4: Prevalent Cases of Urinary Incontinence in United States (2013-2023)
Figure 5: Percentage Distribution ofUrinary Incontinence by Sub Types in United States (2016)
Figure 6: Prevalent Cases of Urinary Incontinence in Germany (2013-2023)
Figure 7: Percentage Distribution ofUrinary Incontinence by Sub Types in Germany (2016)
Figure 8: Prevalent Cases of Urinary Incontinence in France (2013-2023)
Figure 9: Percentage Distribution ofUrinary Incontinence by Sub Types in France (2016)
Figure 10: Prevalent Cases of Urinary Incontinence in United Kingdom (2013-2023)
Figure 11: Percentage Distribution ofUrinary Incontinence by Sub Types in United Kingdom (2016)
Figure 12: Prevalent Cases of Urinary Incontinence in Spain (2013-2023)
Figure 13: Percentage Distribution ofUrinary Incontinence by Sub Types in Spain (2016)
Figure 14: Prevalent Cases of Urinary Incontinence in Italy (2013-2023)
Figure 15: Percentage Distribution ofUrinary Incontinence by Sub Types in Italy (2016)
Figure 16: Prevalent Cases of Urinary Incontinence in Japan (2013-2023)
Figure 17: Percentage Distribution ofUrinary Incontinence by Sub Types in Japan (2016)
Figure 18:Treatment algorithm for Children with Urinary Incontinence
Figure 19:Treatment algorithm for Men with Urinary Incontinence
Figure 20:Treatment algorithm for Women with Urinary Incontinence
Figure 21: Total 7 Major Market Size of Urinary Incontinence in USD, Million (2016)
Figure 22: Total 7 Major Market Size of Urinary Incontinence in USD, Million (2023)
Figure 23: United States Market Size of Urinary Incontinence in USD, Million (2013-2023)
Figure 24: Germany Market Size of Urinary Incontinence in USD, Million (2013-2023)
Figure 25: France Market Size of Urinary Incontinence in USD, Million (2013-2023)
Figure 26: United Kingdom Market Size of Urinary Incontinence in USD, Million (2013-2023)
Figure 27: Spain Market Size of Urinary Incontinence in USD, Million (2013-2023)
Figure 28: Italy Market Size of Urinary Incontinence in USD, Million (2013-2023)
Figure 29: Japan Market Size of Urinary Incontinence in USD, Million (2013-2023)
Figure 30: Market Drivers for Urinary Incontinence
Figure 31: Market Barriers for Urinary Incontinence
  • United States Overactive Bladder Therapeutics Market Report 2017
    Published: 29-Sep-2017        Price: US 3800 Onwards        Pages: 104
    In this report, the United States Overactive Bladder Therapeutics market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report splits the United States market into seven regions: - The West - Southwest - The Middle Atlantic - New England - The South - The Midwest with sales (volume), revenue (value), market share and......
  • Global Overactive Bladder Therapeutics Sales Market Report 2017
    Published: 26-Sep-2017        Price: US 4000 Onwards        Pages: 107
    In this report, the global Overactive Bladder Therapeutics market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report split global into several key Regions, with sales (K Units), revenue (Million USD), market share and growth rate of Overactive Bladder Therapeutics for these regions, from 2012 to 2022 (forecast), covering - United States - China......
  • Interstitial Cystitis (Painful Bladder Syndrome) - Pipeline Review, H2 2017
    Published: 19-Sep-2017        Price: US 2000 Onwards        Pages: 90
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Interstitial Cystitis (Painful Bladder Syndrome) - Pipeline Review, H2 2017, provides an overview of the Interstitial Cystitis (Painful Bladder Syndrome) (Genito Urinary System And Sex Hormones) pipeline landscape.Interstitial cystitis also called painful bladder syndrome is a chronic condition in which person experience bladder pressure, bladder pain and sometimes pelvic pain, ranging from mild discomfort to ......
  • Global Overactive Bladder Therapeutics Market Research Report 2017
    Published: 14-Sep-2017        Price: US 2900 Onwards        Pages: 104
    In this report, the global Overactive Bladder Therapeutics market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Overactive Bladder Therapeutics in these regions, from 2012 to 2022 (forecast), covering - North America - Eu......
  • Pyelonephritis - Pipeline Review, H2 2017
    Published: 12-Sep-2017        Price: US 2000 Onwards        Pages: 69
    Pyelonephritis - Pipeline Review, H2 2017 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Pyelonephritis - Pipeline Review, H2 2017, provides an overview of the Pyelonephritis (Infectious Disease) pipeline landscape. Pyelonephritis is a specific type of urinary tract infection (UTI) that generally begins in urethra or bladder and travels up into kidneys. Signs and symptoms include fever, abdominal pain, freque......
  • Nocturnal Enuresis -Epidemiology Forecast to 2025
    Published: 01-Sep-2017        Price: US 2750 Onwards        Pages: 40
    DelveInsight "Nocturnal Enuresis - Epidemiology Forecast To 2025" provides an overview of the epidemiology trends of Nocturnal Enuresis in seven major markets (US, France, Germany, Italy, Spain, UK and Japan). It includes 10 years epidemiology historical and forecasted data of Nocturnal Enuresis prevalent or incident cases segmented by age, sex and subpopulations. The Report also discusses the prevailing risk factors, disease burden with special emphasis on the unmet medical need associated with......
  • Nocturnal Enuresis - Market Insights, Epidemiology and Market Forecast - 2025
    Published: 01-Sep-2017        Price: US 5750 Onwards        Pages: 70
    DelveInsight's "Nocturnal Enuresis - Market Insights, Epidemiology and Market Forecast - Market Insights, Epidemiology and Market Forecast - 2025" report provides an overview of the disease and in depth research related to Nocturnal Enuresis - Market Insights, Epidemiology and Market Forecast for the 7MM (United States, Germany, France, Italy, Spain and UK) for the study period undertaken from 2015-2025. This report provides understanding of the patients affected, diagnosed patter......
  • Global Urinary Tract Infection Treatment Market 2017-2021
    Published: 09-Aug-2017        Price: US 3500 Onwards        Pages: 78
    About Urinary Tract Infection Treatment UTI is an infection occurred in any part of the urinary system. The infection mostly involves the lower part of the urinary tract. UTI can be classified into different types depending on the portion of the urinary system affected. Women are comparatively at a higher risk of developing UTI as compared with men since the urethra of the women is comparatively smaller than men and is also closer to the anus. This anatomical structure of the urinary trac......
  • Global Overactive Bladder Industry Market Research 2017
    Published: 02-Aug-2017        Price: US 2600 Onwards        Pages: 163
    In this report, we analyze the Overactive Bladder industry from two aspects. One part is about its production and the other part is about its consumption. In terms of its production, we analyze the production, revenue, gross margin of its main manufacturers and the unit price that they offer in different regions from 2012 to 2017. In terms of its consumption, we analyze the consumption volume, consumption value, sale price, import and export in different regions from 2012 to 2017. We also make a......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs